Caplin Point Laboratories Ltd Financials

Market Capitalization ₹153.38 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	28.71
Forward PE	20.16
Price to Sales TTM	₹7.92
Price to Book MRQ	₹5.53
Enterprise to Revenue	7.90
Enterprise to EBITDA	23.67

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2025-03-31
Most Recent Quarter	2025-03-31
Profit Margin	27.68%
Operating Margin	30.06%
Return on Assets TTM	12.30%
Return on Equity TTM	20.68%

Income Statement

Revenue TTM	₹19,374,700,544
Revenue per Share TTM	₹254.94
Quarterly Revenue Growth	10.40%
Gross Profit TTM	₹11,666,299,904
EBITDA	₹7,433,400,000
Net Income to Common TTM	₹5,363,100,160
Diluted EPS TTM	₹70.28
Quarterly Earnings Growth YoY	17.30%

Balance Sheet

Total Cash MRQ	₹9,027,399,680
Total Cash per Share MRQ	₹118.72
Total Debt MRQ	₹
Total Debt to Equity MRQ	0.17
Current Ratio MRQ	6.97
Book Value per Share MRQ	₹365.07

Cash Flow

Operating Cash Flow TTM	₹4,323,700,224
Levered Free Cash Flow TTM	₹1,474,550,016

CAPLIPOINT Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	76,011,696
Float Shares	19,263,298
Avg 10 Volume	120,736
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	73.29%
% Held by Institutions	4.63%

Stock Price Summary

Beta	0.30
Fifty Two Week Low	₹1408.00
Fifty Two Week High	₹2641.00
Fifty Two Week Change	29.56%
Day 50 MA	₹2047.87
Day 200 MA	₹2067.86

Dividends and Splits

Forward Annual Dividend Rate	₹6.00
Forward Annual Dividend Yield	0.30%
Trailing Annual Dividend Rate	₹5.50
Trailing Annual Dividend Yield	0.27%
Payout Ratio	7.12%
Dividend Date
Ex Dividend Date	2025-05-30
Last Split Factor
Last Split Date	2016-10-19